Immunogen Inc. buy JPMorgan Chase & Co.
Start price
13.09.23
/
50%
€15.24
Target price
13.09.24
€20.50
Performance (%)
90.15%
End price
14.09.24
-
Summary
This prediction is currently being closed. With a performance of 90.15% the BUY prediction by JPMorgan_Chase___Co_ is a big success. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Immunogen Inc. | - | - | - |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Immunogen Inc. diskutieren
ImmunoGen, Inc. (NASDAQ: IMGN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $22.00 price target on the stock, up previously from $9.00.
Ratings data for IMGN provided by MarketBeat
In the thread Trading Immunogen Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten